Abstract
Objective: The aim of our study was to examine why real-world practices and attitudes regarding quantitative measurements of rheumatoid arthritis (RA) have received limited attention. Methods: An e-mail survey asked US rheumatologists to self-report on their use of quantitative measurements (metric). Results: Among 439 respondents, metric rheumatologists (58%) were more likely to be in group practice and to use tumor necrosis factor inhibitors. The quantitative tools most commonly used were the Health Assessment Questionnaire (35.5%) and the Routine Assessment of Patient Index Data 3 (27.1%). Reasons for not measuring included time needed and electronic availability. Based on simulated case scenarios, providing more quantitative information increased the likelihood that a patient would change to a different disease-modifying antirheumatic drug or biologic. Conclusion: Routine use of quantitative measurement for patients in the United States with RA is increasing over time but remains low.
Original language | English (US) |
---|---|
Pages (from-to) | 40-44 |
Number of pages | 5 |
Journal | Journal of Rheumatology |
Volume | 45 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2018 |
Externally published | Yes |
Keywords
- Rheumatoid arthritis
- Rheumatology
- Survey
ASJC Scopus subject areas
- Immunology and Allergy
- Rheumatology
- Immunology